Free Trial

Exponent (EXPO) Projected to Post Quarterly Earnings on Thursday

Exponent logo with Business Services background

Key Points

  • Exponent (EXPO) is set to announce its Q3 2025 earnings on October 30, 2025, with analysts projecting earnings of $0.50 per share and revenue of $131.779 million.
  • In its last earnings report on July 31, 2025, Exponent exceeded analyst expectations with a net margin of 18.35% and a year-over-year revenue increase of 7.3%.
  • CEO Catherine Corrigan recently sold 4,930 shares of Exponent stock, resulting in a 5.62% decrease in her ownership of the company.
  • Interested in Exponent? Here are five stocks we like better.

Exponent (NASDAQ:EXPO - Get Free Report) is expected to post its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Exponent to post earnings of $0.50 per share and revenue of $131.7790 million for the quarter. Parties may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 30, 2025 at 4:30 PM ET.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.57 EPS. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Exponent Price Performance

NASDAQ:EXPO opened at $69.14 on Thursday. Exponent has a 1-year low of $63.81 and a 1-year high of $112.75. The stock has a market cap of $3.49 billion, a P/E ratio of 34.57 and a beta of 0.91. The firm has a 50-day moving average of $69.47 and a two-hundred day moving average of $73.61.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Friday, September 5th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date was Friday, September 5th. Exponent's payout ratio is currently 60.00%.

Insider Activity

In related news, CEO Catherine Corrigan sold 4,930 shares of the stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the transaction, the chief executive officer owned 82,753 shares in the company, valued at approximately $5,529,555.46. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Joseph Sala sold 1,595 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,326 shares of company stock worth $1,133,059. Company insiders own 1.60% of the company's stock.

Institutional Investors Weigh In On Exponent

A number of large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE boosted its position in Exponent by 15.9% during the second quarter. Bank of America Corp DE now owns 645,726 shares of the business services provider's stock worth $48,242,000 after purchasing an additional 88,350 shares during the period. Invesco Ltd. boosted its position in Exponent by 3.3% during the second quarter. Invesco Ltd. now owns 554,733 shares of the business services provider's stock worth $41,444,000 after purchasing an additional 17,930 shares during the period. Bamco Inc. NY boosted its position in Exponent by 49.9% during the second quarter. Bamco Inc. NY now owns 501,239 shares of the business services provider's stock worth $37,448,000 after purchasing an additional 166,930 shares during the period. Ameriprise Financial Inc. boosted its position in shares of Exponent by 3.1% in the second quarter. Ameriprise Financial Inc. now owns 282,910 shares of the business services provider's stock valued at $21,136,000 after acquiring an additional 8,398 shares during the period. Finally, First Trust Advisors LP bought a new stake in shares of Exponent in the second quarter valued at approximately $18,377,000. Institutional investors own 92.37% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a "hold (c-)" rating on shares of Exponent in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Exponent has a consensus rating of "Hold".

Check Out Our Latest Report on Exponent

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Earnings History for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.